Pacific Life Re invests in VC Quantonation

Pacific Life Re has invested in Quantonation , a venture capital fund specializing in quantum technology and deep physics.

Founded in 2018 with offices in Paris and Boston, Quantonation invests in startups leveraging deep physics across verticals such as cybersecurity, pharmaceutics design, finance and manufacturing. 

Pacific Life Re’s partnership with Quantonation is said to promote the development of quantum technology products in areas such as virtual drug testing, medical screening, and AI-based diagnostics – with potential direct impact on life and health reinsurance.

“The expected enhancements of quantum technologies for heavy computational problems will prove incredibly helpful for future risks or behaviours forecasting and prevention. Areas of application for life and medical risks and beyond are limitless. I am very proud that Pacific Life Re actively supports Quantonation and their pool of promising tech startups.” – Vincent Lepez, Managing Director, Pacific Life Re Europe.

“We are thrilled to welcome Pacific Life Re as a strategic investor in Quantonation. As financial services & insurance is one of the shorter-term applications of quantum technologies, we believe that our collaboration with Pacific Life Re will enable us to develop innovative use cases with our portfolio companies and help accelerate the adoption of quantum technologies in the financial industry.” – Olivier Tonneau, Partner, Quantonation.